Abstract
Background
The majority of studies addressing traumatic optic neuropathy (TON) have focused on drugs, proteins, cytokines, and various surgical techniques. A recent study reported that transplantation of human umbilical cord blood stem cells (hUCBSCs) achieved therapeutic effects on TON, but the exact effects on optic nerve injury are still unknown, and the mechanisms underlying nerve protection remain poorly understood.
Methods
A total of 135 healthy Sprague–Dawley adult rats were randomly assigned to three groups: sham-surgery, model and transplantation, with 45 rats in each group. TON was induced in the model and transplantation groups via optic nerve crush injury. The crush injury was not performed in the sham-surgery group. Seven days after the injury, 106 hUCBSCs were injected into the rat vitreous cavity of transplantation group, and an equal volume of physiological saline was administered to the model and sham-surgery groups. Pathological observation of rat retina tissues was performed by hematoxylin–eosin (H&E) staining at days 3, 7, 14, 21 and 28 post-surgery. The number of retinal ganglion cells (RGCs) and mRNA expression levels of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) were assessed by the Fluorogold (FG) retrograde labeling and reverse transcriptase–polymerase chain reaction (RT–PCR) methods, respectively.
Results
The number of labeled RGCs and the expression of BDNF and GDNF mRNA obviously increased, and pathological injury was significantly ameliorated in the transplantation group compared to the model group (P < 0.05).
Conclusions
Via intravitreal transplantation, the hUCBSCs resulted in a significant increase in the survival of the RGCs, and improved pathological changes in the rat retina, following TON. The protective mechanism is correlated with the continuous secretion of BDNF and GDNF in vivo of retina in optic nerve injury rats by the transplanted hUCBSCs.
Similar content being viewed by others
References
Lagrèze W (2009) Treatment of optic neuropathies—state of the art. Klin Monatsbl Augenheilkd 226:875–880
Selhorst JB, Chen Y (2009) The optic nerve. Semin Neurol 29:29–35
Wu N, Yin ZQ, Wang Y (2008) Traumatic optic neuropathy therapy: an update of clinical and experimental studies. J Int Med Res 36:883–889
Steinsapir KD (1999) Traumatic optic neuropathy. Curr Opin Ophthalmol 10:340–342
Osborne NN, Chidlow G, Layton CJ, Wood JP, Casson RJ, Melena J (2004) Optic nerve and neuroprotection strategies. Eye 18:1075–1084
Mattson MP (2001) Stem cells as therapeutics for neurodegenerative disorders? Expert Rev Neurother 1:267–273
Knudtzon S (1974) In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 43:357–361
Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM (1995) A functional comparison of CD34 + CD38- cells in cord blood and bone marrow. Blood 86:3745–3753
Bjugstad KB, Redmond DE Jr, Teng YD, Elsworth JD, Roth RH, Blanchard BC, Snyder EY, Sladek JR Jr (2005) Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: a return to control measures. Cell Transplant 14:183–192
Haas S, Weidner N, Winkler J (2005) Adult stem cell therapy in stroke. Curr Opin Neurol 18:59–64
Garbuzova-Davis S, Willing AE, Saporta S, Bickford PC, Gemma C, Chen N, Sanberg CD, Klasko SK, Borlongan CV, Sanberg PR (2006) Novel cell therapy approaches for brain repair. Prog Brain Res 157:207–222
Peinado-Ramon P, Salvador M, Villegas-Perez MP, Vidal-Sanz M (1996) Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. A quantitative in vivo study. Invest Ophthalmol Vis Sci 37:489–500
Wittekind D (2003) Traditional staining for routine diagnostic pathology including the role of tannic acid. 1. Value and limitations of the hematoxylin-eosin stain. Biotech Histochem 78:261–270
Wilhelm H (2004) Traumatic optic neuropathy—the present state. Klin Monatsbl Augenheilkd 221:702–705
Lee AG (2000) Traumatic optic neuropathy. Ophthalmology 107:814
Zapała J (2005) Guidelines for the management of posttraumatic optic nerve neuropathy. Klin Oczna 107:263–265
Sieśkiewicz A, Łysoń T, Mariak Z, Rogowski M (2008) Endoscopic decompression of the optic nerve in patients with post-traumatic vision impairment. Klin Oczna 110:155–158
Li H, Zhou B, Shi J, Cheng L, Wen W, Xu G (2008) Treatment of traumatic optic neuropathy: our experience of endoscopic optic nerve decompression. J Laryngol Otol 122:1325–1329
Zuo KJ, Shi JB, Wen WP, Chen HX, Zhang XM, Xu G (2009) Transnasal endoscopic optic nerve decompression for traumatic optic neuropathy: analysis of 155 cases. Zhonghua Yi Xue Za Zhi 89:389–392
Bojanić I, Golubić Cepulić B (2006) Umbilical cord blood as a source of stem cells. Acta Med Croat 60:215–225
Garbuzova-Davis S, Willing AE, Zigova T, Saporta S, Justen EB, Lane JC, Hudson JE, Chen N, Davis CD, Sanberg PR (2003) Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res 12:255–270
Newcomb JD, Sanberg PR, Klasko SK, Willing AE (2007) Umbilical cord blood research: current and future perspectives. Cell Transplant 16:151–158
Canque B, Camus S, Dalloul A, Kahn E, Yagello M, Dezutter-Dambuyant C, Schmitt D, Schmitt C, Gluckman JC (2000) Characterization of dendritic cell differentiation pathways from cord blood CD34(+)CD7(+)CD45RA(+) hematopoietic progenitor cells. Blood 96:3748–3756
Bacigalupo A, Hows J, Gordon-Smith EC, Gluckman E, Van Lint MT, Congiu M, James DC, Barrett AJ, Gmur J, De Planque MM (1988) Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party. Bone Marrow Transplant 3:531–535
Slater BJ, Mehrabian Z, Guo Y, Hunter A, Bernstein SL (2008) Rodent anterior ischemic optic neuropathy (rAION) induces regional retinal ganglion cell apoptosis with a unique temporal pattern. Invest Ophthalmol Vis Sci 49:3671–3676
Dasari VR, Spomar DG, Gondi CS, Sloffer CA, Saving KL, Gujrati M, Rao JS, Dinh DH (2007) Axonal remyelination by cord blood stem cells after spinal cord injury. J Neurotrauma 24:391–410
Parrilla-Reverter G, Agudo M, Sobrado-Calvo P, Salinas-Navarro M, Villegas-Perez MP, Vidal-Sanz M (2009) Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study. Exp Eye Res 89:32–41
van Adel BA, Kostic C, Deglon N, Ball AK, Arsenijevic Y (2003) Delivery of ciliary neurotrophic factor via lentiviral-mediated transfer protects axotomized retinal ganglion cells for an extended period of time. Hum Gene Ther 14:103–115
Martin KR, Quigley HA, Zack DJ, Levkovitch-Verbin H, Kielczewski J, Valenta D, Baumrind L, Pease ME, Klein RL, Hauswirth WW (2003) Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Invest Ophthalmol Vis Sci 44:4357–4365
Leaver SG, Cui Q, Plant GW, Arulpragasam A, Hisheh S, Verhaagen J, Harvey AR (2006) AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells. Gene Ther 13:1328–1341
Kao CH, Chen SH, Chio CC, Lin MT (2008) Human umbilical cord blood-derived CD34+ cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors. Shock 29:49–55
Author information
Authors and Affiliations
Corresponding author
Additional information
There is no financial relationship with the organization that sponsored the research. The authors have full control of all primary data, and we agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review our data upon request.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhao, T., Li, Y., Tang, L. et al. Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats. Graefes Arch Clin Exp Ophthalmol 249, 1021–1028 (2011). https://doi.org/10.1007/s00417-011-1635-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-011-1635-7